Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today

US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.

from NDTV News - Special https://ift.tt/2GsIzEz

Comments

Popular posts from this blog

OnePlus 13s Price in India Leaked Ahead of Launch on June 5